GSK256073

GSK256073 is an experimental drug which acts as a potent and selective agonist for the Hydroxycarboxylic acid receptor 2 (GPR109A). It reduces blood sugar levels and was trialed unsuccessfully as a potential treatment for diabetes, but continues to be used for research into the function of the HCA2 receptor.^{[1][2][3][4][5]}

GSK256073

Identifiers
IUPAC name 8-chloro-3-pentyl-7H-purine-2,6-dione
CAS Number	862892-90-8
PubChem CID	46215799
IUPHAR/BPS	8470
ChemSpider	35033254
UNII	1VI94C980K
ChEMBL	ChEMBL3730241
Chemical and physical data
Formula	C10H13ClN4O2
Molar mass	256.69 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCCCN1C2=C(C(=O)NC1=O)NC(=N2)Cl
InChI InChI=1S/C10H13ClN4O2/c1-2-3-4-5-15-7-6(12-9(11)13-7)8(16)14-10(15)17/h2-5H2,1H3,(H,12,13)(H,14,16,17) Key:CGAMDQCXAAOFSR-UHFFFAOYSA-N